Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2026)

PROCEPT BioRobotics has reported Asset Writedowns and Impairment over the past 7 years, most recently at $274000.0 for Q1 2026.

  • Quarterly Asset Writedowns and Impairment fell 16.97% to $274000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $163000.0 through Mar 2026, down 86.07% year-over-year, with the annual reading at $219000.0 for FY2025, 73.93% down from the prior year.
  • Asset Writedowns and Impairment was $274000.0 for Q1 2026 at PROCEPT BioRobotics, up from -$347000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $581000.0 in Q3 2023 and troughed at -$347000.0 in Q4 2025.
  • The 5-year median for Asset Writedowns and Impairment is $207000.0 (2023), against an average of $199166.7.
  • Year-over-year, Asset Writedowns and Impairment surged 567.82% in 2023 and then plummeted 190.36% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$25000.0 in 2022, then soared by 2424.0% to $581000.0 in 2023, then tumbled by 33.91% to $384000.0 in 2024, then tumbled by 190.36% to -$347000.0 in 2025, then soared by 178.96% to $274000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Asset Writedowns and Impairment are $274000.0 (Q1 2026), -$347000.0 (Q4 2025), and $76000.0 (Q3 2025).